News, reviews and podcasts from annual scientific meetings and symposiums around the world.
ASCO 2025: GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for people with diabetes
A large observational study of more than 170,000 patients with diabetes and obesity in the…